Heeding a black box warning, the FDA’s most severe warning label, could mean the difference between life and death for a patient with cancer, according to Mary Jo Sarver, ARNP, AOCN, CRNI, VA-BC, LNC.
The majority of patients with cancer pain need opioids. But in the midst of an ongoing opioid crisis in the United States, how do providers safely prescribe them to their patients? According to Jeannine Brant, PhD, APRN, AOCN, FAAN, this requires a safe and balanced approach to pain and symptom management.
Evidence-Based Statistics on Complete Prevention and Rapid Sustained Elimination of Chemoradiation Mucositis by High-Potency Polymerized Cross-Linked Sucralfate
This report evaluates the quality of that evidence and provides a plain language review of the statistics regarding the efficacy of High-Potency Polymerized Cross-linked Sucralfate as well as the inherent limitation of some guideline-supported therapies.
The prevalence of fatigue is very high across the cancer continuum, with approximately 60% of advanced cancer patients experiencing this condition.
In patients undergoing radiation therapy for painful bone metastases, results from a multicenter randomized trial suggest that pain management education may reduce pain intensity. According to data presented at the 2017 Palliative and Supportive Care in Oncology Symposium, controlled pain, which was defined as a pain score lower than 5 (out of 10), was reached faster and by more patients with the addition of nurse-led pain education compared with standard of care. However, no significant differences were found between the groups in quality of life.
Scalp cooling devices that allow patients treated with chemotherapy to retain their hair are used more commonly in Europe than in the United States, but this may be about to change now that the FDA has approved 2 scalp cooling devices: the DigniCap (approved in 2015) and the Paxman scalp cooling device (approved in 2017).
The World Health Organization describes the impact of cancer-related disability on activities of daily living and function according to patent-reported outcomes and QOL measures, and identifies unmet needs for people with impairments due to cancer.
A panel of experts has developed a preliminary set of the first Multinational Association of Supportive Care in Cancer (MASCC) guidelines for the management of cancer-related fatigue. These guidelines were based on extensive literature reviews and meetings among panel members.
According to a recent assessment of bowel dysfunction–related needs, the hardships for colorectal cancer (CRC) survivors continue long after leaving the operating room, and survivors desire more information and strategies to help cope with unexpected changes to their bowel patterns, researchers said at the 2015 Gastrointestinal Cancers Symposium held in San Francisco, CA.
Page 1 of 2
Results 1 - 10 of 13
Results 1 - 10 of 13